Skip to content

    Synthace Blog

      Filter by Topic

      Applications

      Optimizing Construct Assembly with Synthace

      Synthace improved robustness of BsaI DNA-assembly resulting in >95% correct constructs, achieved a 74% time saving, and reduced tip use by 22%.
      Synthace Team
      Synthace Team
       4 min
      Lab of the Future

      A Universal Language for Biology

      Put simply, biological research is lagging behind in its use of automation when compared to engineering industries. What can be done about it?
      Synthace Team
      Synthace Team
       5 min
      Applications

      The cell and gene therapy market: why it matters

      The cell and gene therapy market: why it matters
      Synthace Team
      Synthace Team
       11 min
      Lab of the Future

      Perspectives on closing the loop in big pharma

      Thoughts on Lab of the Future from the ELRIG Drug Discovery 2018 conference and the End Points News ‘Pharma ROI’ summit in 2018.
      Synthace Team
      Synthace Team
       8 min
      People

      An interview with Dr Susan Shiff: Real-world data

      In this interview, we sit down with Dr. Susan Shiff MBA to discuss how data is obtained, analyzed, and used for meaningful patient insights.
      Synthace Team
      Synthace Team
       4 min
      Lab automation

      Where is the return on investment (ROI) from lab automation?

      Where is the return on investment (ROI) from lab automation? It's bigger, and more pervasive, than you think. In this article, we go through the full list.
      Synthace Team
      Synthace Team
       13 min
      Lab automation

      Automating your Cell Therapy QC assays

      At Synthace, we believe that to build the QC Lab of the Future we need to start by removing the burden of manual assay prep from lab scientists.
      Synthace Team
      Synthace Team
       12 min
      Applications

      Cell & Gene Therapy Manufacturing: Addressing the Cost Issue

      Current manufacturing technologies are sub-optimal and costly, involving open systems and manual pipetting with culture flasks instead of bioreactors.
      Synthace Team
      Synthace Team
       4 min
      Applications

      Synthace Expert Interviews: Cell and Gene Therapies with Dr Damian Marshall (part 2)

      Synthace Expert Interviews: Cell and Gene Therapies with Dr Damian Marshall (part 2)
      Synthace Team
      Synthace Team
       9 min